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ABSTRACT Central nervous system (CNS) disease is one of the most common ex-
trarespiratory tract complications of inﬂuenza A virus infections. Remarkably, zoonotic
H5N1 virus infections are more frequently associated with CNS disease than seasonal or
pandemic inﬂuenza viruses. Little is known about the interaction between inﬂuenza A
viruses and cells of the CNS; therefore, it is currently unknown which viral factors are im-
portant for efﬁcient replication. Here, we determined the replication kinetics of a sea-
sonal, pandemic, zoonotic, and lab-adapted inﬂuenza A virus in human neuron-like (SK-
N-SH) and astrocyte-like (U87-MG) cells and primary mouse cortex neurons. In general,
highly pathogenic avian inﬂuenza (HPAI) H5N1 virus replicated most efﬁciently in all
cells, which was associated with efﬁcient attachment and infection. Seasonal H3N2 and
to a lesser extent pandemic H1N1 virus replicated in a trypsin-dependent manner in SK-
N-SH but not in U87-MG cells. In the absence of trypsin, only HPAI H5N1 and WSN vi-
ruses replicated. Removal of the multibasic cleavage site (MBCS) from HPAI H5N1 virus
attenuated, but did not abrogate, replication. Taken together, our results showed that
the MBCS and, to a lesser extent, the ability to attach are important determinants for ef-
ﬁcient replication of HPAI H5N1 virus in cells of the CNS. This suggests that both an al-
ternative hemagglutinin (HA) cleavage mechanism and preference for -2,3-linked sialic
acids allowing efﬁcient attachment contribute to the ability of inﬂuenza A viruses to rep-
licate efﬁciently in cells of the CNS. This study further improves our knowledge on po-
tential viral factors important for the neurotropic potential of inﬂuenza A viruses.
IMPORTANCE Central nervous system (CNS) disease is one of the most common ex-
trarespiratory tract complications of inﬂuenza A virus infections, and the frequency
and severity differ between seasonal, pandemic, and zoonotic inﬂuenza viruses.
However, little is known about the interaction of these viruses with cells of the CNS.
Differences among seasonal, pandemic, and zoonotic inﬂuenza viruses in replication
efﬁcacy in CNS cells, in vitro, suggest that the presence of an alternative HA cleav-
age mechanism and ability to attach are important viral factors. Identifying these vi-
ral factors and detailed knowledge of the interaction between inﬂuenza virus and
CNS cells are important to prevent and treat this potentially lethal CNS disease.
KEYWORDS CNS disease, H1N1, H3N2, H5N1, inﬂuenza A virus, encephalitis,
extrarespiratory, pathogenesis, viral replication, virus attachment
One of the most common extrarespiratory complications of inﬂuenza virus infectionis central nervous system (CNS) disease (1, 2). Clinically, CNS disease can range
from mild febrile seizures to severe or even fatal meningoencephalitis (2, 3). Although
most studies on inﬂuenza virus-associated CNS disease have focused on inﬂuenza A
viruses, viruses of type B are also able to cause CNS disease. This is, however, less
frequently observed (2, 4). Inﬂuenza A viruses, hereinafter referred to as inﬂuenza virus,
have been linked to CNS disease since the 1918 H1N1 pandemic (5, 6), and CNS disease
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has been observed during all subsequent pandemics (7–12) as well as during seasonal
epidemics, with sporadic detection of inﬂuenza virus in the CNS or cerebral spinal ﬂuid
(CSF) of humans (13–15). Zoonotic inﬂuenza viruses only occasionally infect humans,
but when they do, they are frequently associated with severe and systemic disease (1).
Highly pathogenic avian inﬂuenza (HPAI) H5N1 and H7N9 viruses, two recent zoonotic
inﬂuenza viruses, are both associated with CNS disease (16–19). The HPAI H5N1 virus is
possibly the most neurotropic inﬂuenza virus known and has frequently been associ-
ated with CNS disease in humans and in other naturally (20–23) and experimentally
(24–27) infected mammalian species.
In order to infect, replicate in, and spread throughout the CNS, inﬂuenza viruses ﬁrst
have to be able to enter the CNS. Entry of inﬂuenza viruses into the CNS can occur via,
for example, the olfactory (24, 26–28), trigeminal (6, 27, 29, 30), vagus (29–31), and
sympathetic (27, 31) nerves and possibly other cranial nerves. The primary targets of
inﬂuenza viruses are, however, epithelial cells of the respiratory tract (32), which differ
from cells of the CNS. Inﬂuenza virus infection starts with attachment of the virus to
sialic acids (SA) present on host cells (33). Human and avian inﬂuenza viruses attach
preferentially to -2,6- and -2,3-linked SA, respectively, present in the upper and lower
respiratory tracts of humans, respectively (33). In cells of the CNS, little is known about
SA distribution on the different cells at different anatomical locations. One com-
parative study using lectin immunohistochemistry suggested that in humans, both
-2,6 and -2,3 SA are present on neurons and glial cells in many different regions,
including cerebral cortex, hippocampus, brainstem, and cerebellum (34). In the
mouse brain, however, SA distribution is less widespread, and regions with and
without detectable SA are infected with inﬂuenza viruses (34). In another study, it
was found that in human cortex tissue, some neurons only express -2,3 SA,
oligodendrocytes mainly express -2,6 SA, while astrocytes appear to express both
receptors (35). Moreover, both -2,3 and -2,6 SA receptors have been found to be
present on human neuroblastoma SK-N-SH and SH-SY5Y and human glioblastoma
T98G cell lines (36, 37). Given these differential results as well as the fact that SA
usage depends on more than -2,3 and -2,6 SA linkage, e.g., -2,8 SA linkage (38,
39) or even SA-independent entry of the virus (40), more studies should reveal
which viruses are able to attach to cells in the CNS.
In order for progeny viruses to infect new cells, cleavage of the immature surface
protein hemagglutinin (HA) into the biologically activated and infectious form is
required (41). Inﬂuenza viruses that contain a monobasic cleavage site can be cleaved
by trypsin-like serine proteases such as human airway trypsin-like protease (HAT),
transmembrane serine protease 2 (TMPRSS2), TMPRSS4, or matriptase present in the
human respiratory tract (42–44). In the human CNS, expression of HAT in the cerebel-
lum (45) and matriptase mRNA in the frontal and temporal cortices, hippocampus, and
cerebellum have been reported (46). Viruses that contain a multibasic cleavage site
(MBCS), such as the HPAI H5N1 virus, can be cleaved by ubiquitously expressed
subtilisin-like proteases such as furin and PC5/6 (41, 47). This MBCS is an important
factor contributing to the ability to spread systemically, including in the CNS. Although
extrarespiratory spread of HPAI H5N1 virus depends on the presence of the MBCS in
ferrets, insertion of an MBCS into a seasonal H3N2 virus did not result in efﬁcient
systemic replication in ferrets, suggesting that more factors are necessary (24, 48).
Other viruses that are associated with CNS invasion in mice or ferrets are 1918 H1N1
and A/WSN/33 viruses (6, 49, 50). These viruses do not possess an MBCS but use a
different protease-mediated mechanism for HA cleavage, allowing trypsin-independent
replication. Taken together, virus receptor speciﬁcity, receptor availability on host cells,
protease distribution and availability, and HA cleavage mechanism all seem to play
important roles in inﬂuenza virus infection and cell tropism as well as replication
efﬁciency in the respiratory tract and beyond.
To date, not much is known about the replication efﬁciency of different inﬂuenza
viruses, especially seasonal viruses, in cells of the CNS. Thus far, evidence from both in
vivo and in vitro studies suggests that HPAI H5N1 viruses are able to infect and replicate
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in neurons and astrocytes (17, 20–27, 36, 51–54), but a direct comparison of replication
efﬁciency in cells of the CNS between seasonal, zoonotic, and pandemic inﬂuenza
viruses is currently lacking. Similarly, insights into the roles of attachment, protease
availability, and presence of an MBCS on replication efﬁciency in cells of the CNS for
these viruses are lacking. Therefore, we here determined the virus attachment, infec-
tivity, and replication kinetics of a seasonal H3N2, 2009 pandemic H1N1 (pH1N1), HPAI
H5N1, and WSN viruses in human neuroblastoma (SK-N-SH), human astrocytoma
(U87-MG), primary mouse cortex neurons (pmCortex), and Madin-Darby canine kidney
(MDCK) cells. Subsequently, we established the importance of the MBCS for the
replication efﬁciency of HPAI H5N1 virus in cells of the CNS.
RESULTS
HPAI H5N1 virus replicates more efﬁciently in CNS cells than H3N2 and pH1N1
viruses. The replication kinetics of pH1N1, H3N2, HPAI H5N1, and WSN viruses were
determined in SK-N-SH, U87-MG, pmCortex, and MDCK cells in the presence of trypsin.
All viruses replicated efﬁciently in MDCK cells, where HPAI H5N1 virus and H3N2 virus
replicated to higher titers than pH1N1 virus and WSN virus (Fig. 1D). In both SK-N-SH
and U87-MG cells, HPAI H5N1 virus replicated to a signiﬁcantly higher titer (7 log10
50% tissue culture infective dose [TCID50]/ml) than all other viruses (Fig. 1A and B). In
U87-MG and pmCortex cells, only HPAI H5N1 and WSN viruses were able to replicate
(Fig. 1B and C). In addition to HPAI H5N1 virus, SK-N-SH cells supported replication of
pH1N1, H3N2, and WSN viruses, reaching virus titers of 5.7, 3.9, and 3.3, respec-
tively (Fig. 1A). Overall, our results show that HPAI H5N1 and WSN viruses replicated in
all cells investigated and that H3N2 and pH1N1 viruses replicated less efﬁciently in
SK-N-SH cells and not at all in U87-MG cells and pmCortex cells.
HPAI H5N1 and WSN viruses infected cells more efﬁciently than H3N2 and pH1N1
viruses. To determine whether efﬁcient replication was associated with the ability of
the virus to enter and infect host cells, we determined the percentage of infection 8 h
postinfection (hpi) (multiplicity of infection [MOI] of 3) in SK-N-SH, U87-MG, and MDCK
cells, measured by ﬂow cytometry (Fig. 2). In MDCK cells, pH1N1, HPAI H5N1, and WSN
FIG 1 In the presence of trypsin, HPAI H5N1 virus replicates most efﬁciently in SK-N-SH, U87-MG,
pmCortex, and MDCK cells. (A to D) Growth kinetics of pH1N1, H3N2, HPAI H5N1, and WSN viruses in
SK-N-SH, U87-MG, pmCortex, and MDCK cells (MOI of 0.1) in the presence of trypsin. Data are presented
as means  SDs from at least three independent experiments. Two-way analysis of variance (ANOVA)
with Dunnett’s multiple-comparison tests for individual viruses against HPAI H5N1 virus. *, P 0.05; ***,
P 0.001; ****, P 0.0001.
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viruses infected signiﬁcantly more cells than H3N2 virus. In SK-N-SH and U87-MG cells,
HPAI H5N1 and WSN viruses infected signiﬁcantly more cells than H3N2 or pH1N1
viruses.
pH1N1 and H3N2 viruses attach less efﬁciently to SK-N-SH and U87-MG cells
than HPAI H5N1 and WSN viruses. To determine whether there were differences in
attachment between the viruses and whether this was associated with the infection
percentages, we performed a virus attachment assay. The attachment efﬁciency was
scored as follows: inefﬁcient attachment (0% to 5%), low attachment (6% to 25%),
intermediate attachment (26% to 75%), and efﬁcient attachment (76%). HPAI H5N1
virus attached efﬁciently (90%) to all cell lines investigated (Fig. 3). WSN virus
attached efﬁciently (95%) to SK-N-SH and U87-MG cells and intermediately (70%) to
MDCK cells (Fig. 3). Pandemic H1N1 virus attached with intermediate efﬁciency to
SK-N-SH (37%) and MDCK (30%) cells (Fig. 3A, B, and D). Seasonal H3N2 virus attached
with low efﬁciency to SK-N-SH (12%) and intermediate efﬁciency to MDCK (39%) cells
(Fig. 3A, B, and D). Neither pH1N1 nor H3N2 virus attached to U87-MG cells (2%) (Fig.
3A and C). Overall, these results show that pH1N1 and H3N2 viruses attach less
efﬁciently to SK-N-SH and U87-MG cells than H5N1 and WSN viruses.
HPAI H5N1 and WSN viruses replicate in the absence of trypsin, but H3N2 and
pH1N1 viruses do not. To test whether efﬁcient replication is dependent on the
presence of trypsin, we determined the replication kinetics in the absence of trypsin.
Replication of HPAI H5N1 and WSN viruses was not affected by the absence of trypsin
(Fig. 4). In the presence of trypsin, H3N2 and pH1N1 viruses replicated efﬁciently in
SK-N-SH cells but not in the absence of trypsin (Fig. 4A). To further understand this
ﬁnding, we analyzed the presence of speciﬁc host cell proteases known to cleave the
HA protein of H3N2 and pH1N1 viruses (43). We found that neither SK-N-SH nor
U87-MG cells expressed HAT, TMPRSS2, nor TMPRSS4 mRNA, whereas these transcripts
were present in human nasal cell (HN) cultures and human bronchial/tracheal epithelial
(HBTE) cultures (Fig. 5). These results show that HPAI H5N1 and WSN viruses replicate
independently of trypsin and that pH1N1 and H3N2 viruses are dependent on trypsin
for replication in SK-N-SH cells.
The MBCS of HPAI H5N1 virus is important but not solely responsible for
replication in SK-N-SH cells. To determine whether efﬁcient replication of HPAI H5N1
virus in cell culture solely depends on the presence of the MBCS, we generated an H5N1
virus without the MBCS. The replication kinetics of the HPAI H5N1WT (wild-type) virus
was not affected by the presence or absence of trypsin in all cell lines (Fig. 6A).
However, the H5N1ΔMBCS virus, without trypsin, replicated to a lower titer on each cell
line investigated. This phenotype was restored by the addition of trypsin to the culture
medium, allowing the virus to replicate to wild-type levels (Fig. 6A). The reduced
FIG 2 HPAI H5N1 and WSN viruses infect cells more efﬁciently than pH1N1 and H3N2 viruses. Percent-
ages of infection in SK-N-SH, U87-MG, and MDCK cells were determined by FACS 8 hpi with either pH1N1,
H3N2, WSN, or HPAI H5N1 virus (MOI of 3). Data are presented as means  SDs from at least three
independent experiments. Statistical analysis was performed using the two-way ANOVA with Tukey’s
multiple-comparison test. *, P 0.05; ***, P 0.001; ****, P 0.0001.
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replication efﬁciency of H5N1ΔMBCS virus was not explained by the ability of the virus
to infect cells, since this was not affected (Fig. 6B). In order to determine if there were
multiple rounds of infection and that virus detected in the supernatant was not solely
the result of primary infected cells, we investigated the percentage of infection at 8 and
24 hpi with an MOI of 0.1, without trypsin, measured by ﬂow cytometry. We found that
HPAI H5N1WT virus efﬁciently replicated in MDCK, SK-N-SH, and U87-MG cells as
indicated by the increase of infection percentages (Fig. 6C). In contrast, a signiﬁcant
increase for H5N1ΔMBCS virus only was observed in MDCK and U87-MG cells. In SK-N-SH
cells, no increased infection percentage was observed. These results reveal that the
MBCS is important but not solely responsible for efﬁcient replication in MDCK and
U87-MG cells in the absence of trypsin.
DISCUSSION
Here we show that HPAI H5N1 virus replicates more efﬁciently in human and mouse
neuronal cells than seasonal H3N2 and 2009 pandemic H1N1 viruses. Both the ability
to attach efﬁciently and the presence of an MBCS of HPAI H5N1 virus contributed to
efﬁcient replication in cells of the CNS, indicative that these are viral factors that
contribute to the neurotropic potential of inﬂuenza viruses. This ﬁts with the facts that
HPAI H5N1 virus is more frequently associated with CNS disease in humans than
seasonal and pandemic viruses (1) and that this virus is also more often detected in
FIG 3 HPAI H5N1 and WSN viruses attach more efﬁciently to SK-N-SH and U87-MG cells than pH1N1 and H3N2
viruses. Virus attachment of pH1N1, H3N2, HPAI H5N1, and WSN viruses (using 100 hemagglutination units [HAU]
units) to SK-N-SH, U87-MG, and MDCK cells. (A) Percentages of cells to which viruses attached. (B to D)
Representative histograms of SK-N-SH, U87-MG, and MDCK cells. Dotted lines indicate cell control. Data in panel
A are presented as means  SDs from at least three independent experiments. Two-way ANOVA with Tukey’s
multiple-comparison test. ***, P 0.001; ****, P 0.0001.
Viral Factors Important for Replication in CNS Cells Journal of Virology
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tissues of the CNS in experimentally inoculated laboratory animals than seasonal and
pandemic viruses (17, 20–27, 51, 55–58).
The ability of HPAI H5N1 and WSN viruses to replicate efﬁciently in cells of the CNS
seems to be associated with the ability to attach to and infect host cells efﬁciently.
FIG 4 In the absence of trypsin, HPAI H5N1 virus grows most efﬁciently in SK-N-SH, U87-MG, MDCK, and
pmCortex cells. (A to D) Growth kinetics of pH1N1, H3N2, HPAI H5N1, and WSN viruses in SK-N-SH,
U87-MG, MDCK, and pmCortex cells (MOI of 0.1) in the absence of trypsin. Data are presented as
means  SDs from at least three independent experiments. Two-way ANOVA with Dunnett’s multiple-
comparison test against H5N1 virus. **, P 0.01 ***, P 0.001; ****, P 0.0001.
FIG 5 HAT, TMPRSS2, and TMPRSS4 mRNAs are not present in SK-N-SH and U87-MG cells. Presence of
three known HA cleaving enzymes: human airway trypsin (HAT), transmembrane serine protease 2
(TMPRSS2), and TMPRSS4. Positive-control cell lines human nasal cells (HN) and human bronchial/
tracheal epithelial (HBTE) cells did express HAT, TMPRSS2, and TMPRSS4 mRNA.
Siegers et al. Journal of Virology
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Especially, HPAI H5N1 virus which replicated efﬁciently in SK-N-SH and U87-MG cells,
attached to high percentages of cells with high intensity, and infected these cells
efﬁciently. WSN virus attached to and infected high percentages of neuronal cells,
which resulted in multiple rounds of infection in all cells, although to lower titers on
SK-N-SH and U87-MG cells than observed for HPAI H5N1 virus. The latter could be due
to the fact that WSN virus is extensively passaged in suckling mouse brains, thereby
adapting to mouse neuronal cells and not human neuronal cells. Seasonal H3N2 viruses
replicated in SK-N-SH cells, even in the absence of efﬁcient attachment or infection.
Whether this is due to low-afﬁnity binding of H3N2 virus, which cannot be detected by
our assays, is unknown, but it does suggest that efﬁcient attachment, as observed for
H5N1 and WSN viruses on neuronal cells, is not the only viral factor involved in
replication of inﬂuenza viruses in cells of the CNS. The lack of replication of H3N2 and
pH1N1 viruses in U87-MG cells could be explained by both inefﬁcient attachment and
infection.
Efﬁcient replication of inﬂuenza viruses in cells of the CNS seems to depend in part
on the presence of an MBCS or alternative HA cleaving mechanisms. Studies in ferrets,
mice, macaques, and chickens show that introduction or removal of an MBCS has
FIG 6 H5N1 virus without an MBCS replicates less efﬁciently in the absence of trypsin. (A) Replication kinetics of
HPAI H5N1WT and H5N1ΔMBCS viruses in SK-N-SH, U87-MG, and MDCK cells (MOI of 0.1) in the presence or absence
of trypsin. Statistical analysis was performed using a two-way ANOVA with Tukey’s multiple-comparison test
against “H5N1WT  trypsin.” (B) Percentages of infection in SK-N-SH, U87-MG, and MDCK cells were determined
by FACS at 8 hpi with HPAI H5N1WT and H5N1ΔMBCS viruses (MOI of 3). Statistical analysis was performed using the
two-way ANOVA with Bonferroni’s multiple-comparison test. (C) Percentages of infection in SK-N-SH, U87-MG, and
MDCK cells were determined by FACS at 8 and 24 hpi with HPAI H5N1WT and H5N1ΔMBCS viruses at an MOI of 0.1
in the absence of trypsin. Statistical analysis was performed using the two-way ANOVA with Bonferroni’s
multiple-comparison test (8 versus 24 hpi). All data are presented as means  SDs from at least three independent
experiments. *, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001.
Viral Factors Important for Replication in CNS Cells Journal of Virology
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different outcomes based on the virus backbone and host species (24, 48, 59–61). In
vitro, in the absence of trypsin, only HPAI H5N1 and WSN viruses were able to replicate,
indicating that pH1N1 and H3N2 viruses are not able to circumvent the need for
trypsin-like protease for HA cleavage. Removal of the MBCS from HPAI H5N1 virus
resulted in attenuated replication in SK-N-SH and U87-MG cells in the absence of
trypsin but not in pmCortex cells. Viruses without an MBCS that are associated with
replication in cells of the CNS in vivo, such as the 1918 H1N1 and WSN viruses, have an
alternative HA cleavage mechanism (6, 62). The WSN virus lacks a conserved glycosy-
lation site in the neuraminidase making the virus trypsin independent (63) by using the
serine-protease plasmin, which is present in many organ systems besides the respira-
tory tract (64). The 1918 H1N1 virus grows trypsin independent and neuraminidase
dependent in MDCK cells and polarized Calu-3 cells but not in Huh-7 cells (65, 66). Our
observation that neither HAT, TMPRSS2, nor TMPRSS4 is found in SK-N-SH and U87-MG
cells supports the hypothesis that for efﬁcient replication in cells of the CNS, inﬂuenza
viruses require alternative HA cleavage, as shown for the HPAI H5N1, WSN, and 1918
H1N1 viruses. However, it must be noted that there is limited knowledge on the
expression and accessibility of proteases in tissues other than the respiratory tract.
Previous studies on the replication kinetics of inﬂuenza viruses in cells of the CNS
revealed some differences, which can in part be explained by the use of different cells,
virus isolates, and experimental approaches (36, 54). Replication of HPAI H5N1 viruses
in differentiated astrocytic cell lines resulted in efﬁcient replication, similar to our
observations. However, in SH-SY5Y cells, a subclone cell line derived from SK-N-SH cells,
two HPAI H5N1 viruses did not replicate efﬁciently. This discrepancy could be due to
the relatively high MOI used in this study compared to the low MOI we used and which
resulted in efﬁcient replication (36). Furthermore, two pandemic H1N1 viruses did not
replicate in the neuronal or astrocytic cell lines, which ﬁts with our observation, in the
absence of trypsin (54).
Pandemic H1N1 and seasonal H3N2 viruses are occasionally detected in the CNS or
CSF in humans and from experimentally inoculated ferrets and mice, even though
pH1N1 and H3N2 viruses only replicated in SK-N-SH cells in the presence of trypsin
(11–15, 67–70). However, these viruses are rarely isolated in high titers or detected by
immunohistochemistry in the CNS of humans or experimentally inoculated ferrets and
mice, indicating that these viruses might be able to enter the CNS but that replication
is inefﬁcient. This could be attributed to the limited attachment and infection and lack
of an alternative HA cleavage mechanism allowing efﬁcient replication. Previously, we
showed that even in the absence of active virus replication, proinﬂammatory cytokines,
such as interleukin 6 (IL-6), IL-8, and tumor necrosis factor alpha (TNF-), are induced
in the CNS of pH1N1 experimentally inoculated ferrets (71). Future studies should reveal
how both efﬁcient and inefﬁcient replication in neuronal cells can trigger local proin-
ﬂammatory responses, for which HPAI H5N1 and H5N1ΔMBCS viruses might be a good
model.
Taken together, results of our study have shown that the presence of an MBCS and,
to a lesser extent, the ability to attach are important determinants for replication of
HPAI H5N1 virus in cells of the CNS. This suggests that, at least for replication within the
CNS, neurotropic inﬂuenza viruses contain an alternative HA cleavage mechanism and
prefer -2,3-linked sialic acids.
MATERIALS AND METHODS
Cells. Human neuroblastoma (neuron like, SK-N-SH) and human glioblastoma (astrocyte like, U87-
MG) cells were purchased from Sigma-Aldrich and maintained in Eagle minimal essential medium (EMEM;
Lonza, Breda, the Netherlands) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis,
MO, USA), 100 IU/ml penicillin (Lonza, Basel, Switzerland), 100 g/ml streptomycin (Lonza), 2 mM
glutamine (Lonza), 1.5 mg/ml sodium bicarbonate (Cambrex, Wiesbaden, Germany), sodium pyruvate
(Thermo Fisher Scientiﬁc, Waltham, MA, USA) and 1 (0.1 mM) nonessential amino acids(MP Biomedicals
Europe, Illkirch, France). As a control cell line, we have included Madin-Darby canine kidney (MDCK) cells,
since these cells are extensively used for inﬂuenza virus propagation. MDCK cells were maintained in
EMEM supplemented with 10% FBS, 100 IU/ml penicillin, 100 g/ml streptomycin, 2 mM glutamine, 1.5
mg/ml sodium bicarbonate, 1 mM, 10 mM HEPES (Cambrex), and 1 (0.1 mM) nonessential amino acids.
Siegers et al. Journal of Virology
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Viruses. Five viruses were included in this study, a seasonal H3N2 virus (A/Netherlands/213/2003),
pH1N1 virus (A/Netherlands/602/2009), and zoonotic HPAI H5N1 virus (A/Indonesia/5/2005) all isolated
from humans. Neurotropic WSN virus (A/WSN/33) and H5N1 virus lacking an MBCS (H5N1ΔMBCS) were
generated using reverse genetics as described before (72) and passed once on 293T cells and once on
MDCK cells. Experiments involving HPAI H5N1 and H5N1ΔMBCS viruses were performed under biosafety
level 3 conditions.
Isolation and culture of primary mouse cortex neurons. Animals were housed and experiments
were conducted in strict compliance with European guidelines (EU directive on animal testing 86/609/
EEC) and Dutch legislation (Experiments on Animals Act, 1997). Primary mouse cortex tissue was isolated
from embryonic day 17 (E17) to E19 C57BL6 mouse embryos (Charles River Laboratories, Wilmington, MA,
USA). The cultures were pooled cortexes of several mouse embryos originating from one mother. In brief,
the cortex was dissected in ice-cold Hanks’ balanced salt solution (HBSS; Life Technologies) supple-
mented with 20 g/ml gentamicin (Life Technologies) under guidance with a stereomicroscope (Nikon).
Next, tissues were cut to 1 mm3 using a scalpel and digested using medium consisting of HBSS
supplemented with 10 U/ml papain (Sigma), 2.5 U/ml DNase I (Roche), and 4 mM MgCl2 (Sigma-Aldrich)
at 33°C for 15 min. After incubation, cells were washed once in 1 ml of 10% FBS (Life Technologies) in
HBSS to stop the digestion. A second “mechanical digestion” was performed by carefully pipetting up
and down in digestion buffer (without papain). After washing in HBSS twice, cells were counted using a
Moxi Go cell counter (Orﬂo, Ketchum, ID, USA) and seeded on laminin (500 g/ml; Sigma)-coated 1.5H
96-well glass-bottomed plates (Cellvis, Sunnyvale, CA, USA) at a density of 1.0 104 cells/well. For the
ﬁrst 2 h, the cells were cultured in culture medium containing 10% FBS. After 2 h, medium was replaced
with fresh culture medium, without FBS. The culture medium contains primary neuron growth medium
(PNBM; Lonza), GS-21 supplement (Tebu-Bio, Le-Perray-en-Yvelines, France), 5 g/ml gentamicin
(Thermo Fisher), and 2 mM GlutaMAX (Life Technologies). Half of the medium was changed once per
week, and cells were cultured for 7 to 10 days before use.
Replication kinetics. Cells were infected at a multiplicity of infection (MOI) of 0.1. Virus dilutions
were prepared in the cell-speciﬁc culture medium without serum (infection medium, see “Virus titra-
tions”). After 1 h of virus absorption, cells were washed once with fresh infection medium and cultured
in infection medium in the presence or absence of L-1-tosylamide-2-phenylethyl chloromethyl ketone
(TPCK)-treated trypsin (see “Virus titration”). At time points 1, 6, 24, and 48 h postinfection (hpi), 100 l
supernatant was collected and stored at 80°C for subsequent virus titration. All experiments were
performed three times (biological replicates), and each experiment was performed with duplicates
(technical replicates) from which the average was used for statistical analysis.
Virus titrations. The 50% tissue culture infectious dose (TCID50) in cell supernatant was determined
by endpoint titration on MDCK cells, as described before (73). Brieﬂy, 10-fold serial dilutions of cell
supernatants were prepared in infection medium. Infection medium consisted of EMEM, 100 IU/ml
penicillin, 100 g/ml streptomycin, 2 mM glutamine, 1.5 mg/ml sodium bicarbonate, 10 mM HEPES, 1
(0.1 mM) nonessential amino acids, and 1 g/l TPCK-treated trypsin (Sigma-Aldrich). Before inoculation,
MDCK cells were washed twice with phosphate-buffered saline (PBS) to remove remaining FBS. One
hundred microliters of the diluted supernatant was used to inoculate a conﬂuent monolayer of MDCK
cells in 96-well plates. After 1 h at 37°C, the cells were washed once with infection medium, and 200 l
new infection medium was added to each well. Three days after infection, supernatants of infected cell
cultures were tested for agglutinating activity using turkey erythrocytes as an indicator of virus replica-
tion. The titers of infectivity were calculated from three replicates according to the method of Kärber (74).
An initial 1:10 dilution of supernatant resulted in a detection limit of 101.5 TCID50/ml.
Percentage of infection. After 8 hpi (with an MOI of 3) or after 8 and 24 hpi (with an MOI of 0.1),
in the absence of trypsin, cells were collected, ﬁxed, and permeabilized using BD Cytoﬁx/Cytoperm
solution (BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturer’s instructions. Cells were
incubated with 2% normal goat serum (NGS; Dako, Denmark) in PBS for 10 min on ice. Next, inﬂuenza
A virus was detected using a monoclonal antibody against inﬂuenza A virus nucleoprotein (clone HB-65,
1 g/ml; ATCC) or mouse IgG2a isotype control (MAB003, 1 g/ml; Dako) in BD Perm/Wash containing
2% NGS and incubated for 1 h on ice and in the dark. Cells were washed twice and incubated with goat
anti-mouse IgG2a conjugated to Alexa Fluor 488 (8 g/ml; Life Technologies, Inc., the Netherlands) for
1 h in the dark and on ice. After incubation, cells were washed twice and resuspended in ﬂuorescence-
activated cell sorting (FACS) buffer. Cells were measured and data collected using a BD FACSCanto II (BD
Biosciences, USA). Data were analyzed using FlowJo 10 software (Ashland, OR, USA). All experiments were
performed three times (biological replicates), and each experiment included duplicate (technical repli-
cate) measurements from which the average was calculated and used for further analysis.
Virus attachment. For inﬂuenza virus histochemistry, viruses were grown, inactivated, and labeled
as described previously (32). As a control, uninfected MDCK cells and cell debris were harvested and
processed similarly. Subsequently, in a 12-well plate, 2 105 cells were seeded, and 1 day later, the near
conﬂuent monolayers of MDCK, SK-N-SH, and U87-MG cells were harvested, washed in FACS buffer, and
incubated with ﬂuorescein isothiocyanate (FITC)-labeled virus for 1 h at 4°C. After incubation, the cells
were washed twice in FACS buffer and measured using a BD FACSCanto II (BD Biosciences, USA). Data
were analyzed using FlowJo 10 software (Ashland, OR, USA). All experiments were performed three times
(biological replicates), and each experiment was performed with duplicates (technical replicates) from
which the average was used for statistical analysis.
PCR proteases. Since MDCK cells are of canine origin, we have included primary human nasal (HN)
cells (MucilAir, pool of 14 donors; Epithelix, Geneva, Switzerland), and primary human bronchial/tracheal
epithelial cells (HBTE) (catalog number CC-2540, lot 97366, donor 97366: male, Caucasian, 57 years,
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healthy; Lonza) as control cell types for the expression of human HAT, human TMPRSS2, and human
TMPRSS4. Total RNA was isolated from SK-N-SH, U87-MG, HN, and HBTE cells using the High Pure RNA
isolation kit (Roche, Basel, Switzerland) according to the manufacturer’s protocol. cDNA synthesis was
performed using oligo(dT) primers and Superscript IV (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer’s instructions. For detection of HAT-, TMPRSS2-, and TMPRSS4-speciﬁc
mRNAs, primers were used from Böttcher-Friebertshäuser et al. (75). The GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) mRNA was detected using primers GAPDH-FW (5=-TGA ACG GGA AGC TCA
CTG G-3=) and GAPDH-RV (5=-TCC ACC ACC CTG TTG CTG TA-3=) as a control for sample quality. PCR
products were resolved on a 1.5% agarose gel stained with SYBR Safe (Thermo Fisher) and imaged using
a ChemiDoc MP imaging system and ImageLab 5.1 (Bio-Rad, Hercules, CA, USA). To conﬁrm the speciﬁcity
of the primers, PCR products were extracted from the gel and sequenced using a BigDye Terminator v3.1
Cycle sequencing kit (Applied Biosystems) and a 3130XL genetic analyzer (Applied Biosystems), accord-
ing to the instructions of the manufacturer.
Statistical analysis. Statistical analyses were performed using GraphPad Prism 6.0h software (La
Jolla, CA, USA) for Mac. Each speciﬁc test is indicated in the ﬁgure legends. P values of 0.05 were
considered signiﬁcant. All data are presented as means  standard deviations (SDs) from at least three
independent experiments.
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